Good morning, in this edition of Archer’s 2021 Newsletter, we highlight some of the Company’s recent activities and reflect on what has been a special year for Archer.
Last week we published a wrap up of the Q2B Conference that Archer attended in Silicon Valley. The event saw leaders from the global quantum ecosystem meet to discuss the business of quantum computing, and industry expectations in the mid-term.
The Archer team also recently made a significant step in progressing the Company’s biochip technology. We developed our first biochemical reactions for potential applications in on-chip detection and quantification of specific genetic information relevant to viruses and bacteria. The work directly relates to the biochip’s future operation and applications in disease detection.
You may have noticed front-end evidence of our proactive approach to growing the Archer team with the Archer website now updated to include a Careers section. We have a unique team at Archer and we work with some of the very best organisations in the world. We are looking forward to attracting and retaining some of the best talent in deep tech in Australia and internationally.
We are headed into 2022 with confidence, looking back on what was an eventful 2021 for Archer:
I would like to thank our shareholders for their continued support. With the holiday season approaching and a new year only weeks away, I wish you all a wonderful 2021 and I look forward to an exciting 2022.
Dr Mohammad Choucair, FRACI FRSN GAICD
Chief Executive Officer
Archer Materials Limited (ASX: AXE)
Designed by Aaron Knight.